Showing results (41-50 of 296) with videos related to

Sort By:
Pageof 30
BMJ (Clinical Research Ed.)|September 10, 2002
Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studiesFrançois Bonnici, Bernard Keavney, Rory Collins, et al.
BMJ Open|May 4, 2021
Health outcomes in international migrant children: protocol for a systematic reviewAlice Jane Armitage, Michelle Heys, Irina Lut, et al.
JAMA Cardiology|February 2, 2018
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 IndividualsTheingi Aung, Jim Halsey, Daan Kromhout, et al.
Archives of Internal Medicine|October 13, 2010
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individualsRobert Clarke, Jim Halsey, Sarah Lewington, et al.
Circulation Research|February 20, 2016
Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic DiseaseWilliam Herrington, Ben Lacey, Paul Sherliker, et al.
Lancet (London, England)|December 21, 2002
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesSarah Lewington, Robert Clarke, Nawab Qizilbash, et al.
Diabetes, Obesity & Metabolism|June 9, 2022
Hospital costs associated with adverse events in people with diabetes in the UKMi Jun Keng, Jose Leal, Louise Bowman, et al.
Diabetes, Obesity & Metabolism|December 6, 2021
Decrements in health-related quality of life associated with adverse events in people with diabetesMi Jun Keng, Jose Leal, Louise Bowman, et al.
Trials|February 26, 2026
Factors associated with adherence to allocated treatment in the ASCEND trial: a mail-based randomised trial of aspirin and of omega-3 fatty acid supplementation in people with diabetesVichithranie W Madurasinghe, Marion Mafham, Georgina Buck, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney diseaseColin Baigent, Martin Landray, Craig Leaper, et al.
Pageof 30